![Biomedicines | Free Full-Text | Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia Biomedicines | Free Full-Text | Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia](https://pub.mdpi-res.com/biomedicines/biomedicines-05-00016/article_deploy/html/images/biomedicines-05-00016-g002.png?1569308757)
Biomedicines | Free Full-Text | Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia
![Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study) | BMJ Open Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study) | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/12/1/e055351/F1.large.jpg)
Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study) | BMJ Open
![Frontiers | Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment Frontiers | Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment](https://www.frontiersin.org/files/Articles/687806/fimmu-12-687806-HTML/image_m/fimmu-12-687806-g001.jpg)
Frontiers | Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment
![Use of low-dose naltrexone in the management of chronic pain conditions - The Journal of the American Dental Association Use of low-dose naltrexone in the management of chronic pain conditions - The Journal of the American Dental Association](https://jada.ada.org/cms/asset/ade854bf-ee1a-461f-9349-e6ad34cca574/gr3.jpg)
Use of low-dose naltrexone in the management of chronic pain conditions - The Journal of the American Dental Association
Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study | PLOS ONE
![Use of low-dose naltrexone in the management of chronic pain conditions: A systematic review - ScienceDirect Use of low-dose naltrexone in the management of chronic pain conditions: A systematic review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002817720306346-fx1.jpg)
Use of low-dose naltrexone in the management of chronic pain conditions: A systematic review - ScienceDirect
Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study | PLOS ONE
![Biomedicines | Free Full-Text | Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia Biomedicines | Free Full-Text | Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia](https://www.mdpi.com/biomedicines/biomedicines-05-00016/article_deploy/html/images/biomedicines-05-00016-g001-550.jpg)